Giansily-Blaizot Muriel, Thorel Delphine, Khau Van Kien Philippe, Behar Catherine, Romey Marie-Catherine, Mugneret Francine, Schved Jean-François, Claustres Mireille
Inserm, U827, Laboratoire de Génétique de Maladies Rares: Pathologie Moléculaire, Etudes Fonctionnelles et Banques de Données Génétiques, Montpellier, France.
Br J Haematol. 2007 Aug;138(3):359-65. doi: 10.1111/j.1365-2141.2007.06660.x.
Inherited factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder mostly caused by point mutations. Large genomic re-arrangements at F7 locus could account for a fraction of mutant alleles that remain unidentified after DNA sequencing, because they escape conventional polymerase chain reaction (PCR)-based techniques. We report the first systematic screening of F7 for large re-arrangements, by semi-quantitative multiplex PCR of fluorescent fragments targeting the 9 exons and the promoter region. A well-characterised cohort of 43 unrelated patients either apparently homozygous for a F7 point mutation or carrying at least one unidentified F7 mutant allele participated in this study. Two large F7 re-arrangements were identified in two FVII-deficient pedigrees, including a discontinuous deletion involving two distinct portions of F7 whose proximal and distal end junctions were characterised. A simple and efficient method for the routine detection of gross alterations of F7, which accounted for 2.3% of mutant alleles in our sample, is now available in inherited FVII deficiency. This test should complement conventional PCR-based techniques not only in unsolved cases, but also where inheritance pattern analysis is not achievable.
遗传性因子 VII(FVII)缺乏症是一种罕见的常染色体隐性出血性疾病,主要由点突变引起。F7 基因座的大片段基因组重排可能是 DNA 测序后仍未鉴定出的一部分突变等位基因的原因,因为它们逃避了基于常规聚合酶链反应(PCR)的技术。我们通过对靶向 9 个外显子和启动子区域的荧光片段进行半定量多重 PCR,首次对 F7 进行了大片段重排的系统筛查。一个由 43 名无亲缘关系的患者组成的特征明确的队列参与了本研究,这些患者要么明显为 F7 点突变的纯合子,要么携带至少一个未鉴定的 F7 突变等位基因。在两个 FVII 缺乏的家系中鉴定出了两个 F7 大片段重排,包括一个涉及 F7 两个不同部分的不连续缺失,其近端和远端末端连接已得到表征。现在有一种简单有效的方法可用于常规检测 F7 的大片段改变,在我们的样本中,这种改变占突变等位基因的 2.3%,该方法可用于遗传性 FVII 缺乏症。这项检测不仅应在未解决的病例中补充基于常规 PCR 的技术,而且在无法进行遗传模式分析的情况下也应如此。